Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders

被引：0
作者：
Apostolia M. Tsimberidou
Dawn E. Colburn
Mary Alma Welch
Jorge E. Cortes
Srdan Verstovsek
Susan M. O'Brien
Maher Albitar
Hagop M. Kantarjian
Francis J. Giles
机构：
[1] University of Texas,Department of Leukemia
[2] M.D. Anderson Cancer Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2003年 / 52卷
关键词：
Anagrelide; Imatinib mesylate; Combination; Myeloproliferative disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：229 / 234
页数：5
相关论文
共 33 条
  • [1] Sawyers BJ(1997)Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome [comment] Baillieres Clin Haematol 10 223-undefined
  • [2] Buchdunger CL(2001)undefined Biochim Biophys Acta 1551 11-undefined
  • [3] Kantarjian H(2002)undefined N Engl J Med 346 645-undefined
  • [4] Hughes DJ(2002)undefined Blood 100 93a-undefined
  • [5] Kantarjian SF(2001)undefined Semin Oncol 28 9-undefined
  • [6] Kantarjian JM(2002)undefined Blood 100 1590-undefined
  • [7] Kantarjian R(2002)undefined Clin Cancer Res 8 2177-undefined
  • [8] Kantarjian M(2002)undefined Clin Cancer Res 8 2167-undefined
  • [9] Kantarjian undefined(2002)undefined Blood 99 3547-undefined
  • [10] Kantarjian undefined(2003)undefined Blood 101 97-undefined
1234